DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: Comparison of PAX6 and SOX1 expression during neural induction

ACS Chemical Neuroscience

Volumn 3, Issue 6, 2012, Pages 482-491

  Neely, M Diana ^a,b   Litt, Michael J ^a   Tidball, Andrew M ^a,b   Li, Gary G ^a   Aboud, Asad A ^a,b   Hopkins, Corey R ^b,c   Chamberlin, Reed ^d   Hong, Charles C ^a,c   Ess, Kevin C ^a,b   Bowman, Aaron B ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d Genetics Associates Inc   (United States)

Author keywords

Induced pluripotent stem cells; iPS; neural differentiation; neural induction; TGF ; transcription factors

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BETA TUBULIN; BONE MORPHOGENETIC PROTEIN; DMH1; MESSENGER RNA; NOGGIN; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CELL LINEAGE; HUMAN; HUMAN CELL; MOLECULE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CHILD; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MIDDLE AGED; NEURAL INHIBITION; NEURAL STEM CELLS; NEUROGENESIS; NEURONS; PAIRED BOX TRANSCRIPTION FACTORS; PYRAZOLES; QUINOLINES; REPRESSOR PROTEINS; SOXB1 TRANSCRIPTION FACTORS; STEM CELLS;

IPS;

EID: 84862836435     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300029t     Document Type: Article

References (55)

1. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. (Pubitemid 350138099)
2. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., and Thomson, J. A. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
3. Aubry, L., Bugi, A., Lefort, N., Rousseau, F., Peschanski, M., and Perrier, A. L. (2008) Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. U.S.A. 105, 16707-16712.
4. Burridge, P. W., Thompson, S., Millrod, M. A., Weinberg, S., Yuan, X., Peters, A., Mahairaki, V., Koliatsos, V. E., Tung, L., and Zambidis, E. T. (2011) A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 6, e18293.
5. Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., and Studer, L. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275-280.
6. Cooper, O., Hargus, G., Deleidi, M., Blak, A., Osborn, T., Marlow, E., Lee, K., Levy, A., Perez-Torres, E., Yow, A., and Isacson, O. (2010) Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell Neurosci. 45, 258-266.
7. Dias, J., Gumenyuk, M., Kang, H., Vodyanik, M., Yu, J., Thomson, J., and Slukvin, I. (2011) Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev. 20, 1639-1647.
8. Ebert, A. D., Yu, J., Rose, F. F. Jr., Mattis, V. B., Lorson, C. L., Thomson, J. A., and Svendsen, C. N. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280.
9. Lee, G., Chambers, S. M., Tomishima, M. J., and Studer, L. (2010) Derivation of neural crest cells from human pluripotent stem cells. Nat. Protoc. 5, 688-701.
10. Vandekerckhove, B., Vanhee, S., Van Coppernolle, S., Snauwaert, S., Velghe, I., Taghon, T., Leclercq, G., Kerre, T., and Plum, J. (2011) In vitro generation of immune cells from pluripotent stem cells. Front. Biosci. 16, 1488-1504.
11. Zeng, H., Guo, M., Martins-Taylor, K., Wang, X., Zhang, Z., Park, J. W., Zhan, S., Kronenberg, M. S., Lichtler, A., Liu, H. X., Chen, F. P., Yue, L., Li, X. J., and Xu, R. H. (2010) Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One 5, e11853.
12. Attisano, L., and Wrana, J. L. (2002) Signal transduction by the TGF-beta superfamily. Science 296, 1646-1647.
13. Massague, J. (2000) How cells read TGF-beta signals. Nat. Rev. Mol. Cell. Biol. 1, 169-178.
14. Shi, Y., and Massague, J. (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700. (Pubitemid 36724933)
15. James, D., Levine, A. J., Besser, D., and Hemmati-Brivanlou, A. (2005) TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132, 1273-1282. (Pubitemid 40528787)
16. Vallier, L., Alexander, M., and Pedersen, R. A. (2005) Activin/ Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509. (Pubitemid 41556347)
17. Vallier, L., Touboul, T., Brown, S., Cho, C., Bilican, B., Alexander, M., Cedervall, J., Chandran, S., Ahrlund-Richter, L., Weber, A., and Pedersen, R. A. (2009) Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells 27, 2655-2666.
18. Xu, R. H., Sampsell-Barron, T. L., Gu, F., Root, S., Peck, R. M., Pan, G., Yu, J., Antosiewicz-Bourget, J., Tian, S., Stewart, R., and Thomson, J. A. (2008) NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell. 3, 196-206.
19. Chadwick, K., Wang, L., Li, L., Menendez, P., Murdoch, B., Rouleau, A., and Bhatia, M. (2003) Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102, 906-915. (Pubitemid 36917782)
20. Xu, R. H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P., and Thomson, J. A. (2002) BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 20, 1261-1264. (Pubitemid 35462493)
21. Zhang, P., Li, J., Tan, Z., Wang, C., Liu, T., Chen, L., Yong, J., Jiang, W., Sun, X., Du, L., Ding, M., and Deng, H. (2008) Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 111, 1933-1941. (Pubitemid 351451502)
22. D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E., and Baetge, E. E. (2005) Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534-1541. (Pubitemid 41752931)
23. Zhou, J., Su, P., Li, D., Tsang, S., Duan, E., and Wang, F. (2010) High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 28, 1741-1750.
24. Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., and Hill, C. S. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor- Œ≤superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74.
25. Hao, J., Ho, J. N., Lewis, J. A., Karim, K. A., Daniels, R. N., Gentry, P. R., Hopkins, C. R., Lindsley, C. W., and Hong, C. C. (2010) In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem. Biol. 5, 245-253.
26. Hu, B. Y., Weick, J. P., Yu, J., Ma, L. X., Zhang, X. Q., Thomson, J. A., and Zhang, S. C. (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. U.S.A. 107, 4335-4340.
27. Kim, D. S., Lee, J. S., Leem, J. W., Huh, Y. J., Kim, J. Y., Kim, H. S., Park, I. H., Daley, G. Q., Hwang, D. Y., and Kim, D. W. (2010) Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev. 6, 270-281.
28. Nagaoka, M., Si-Tayeb, K., Akaike, T., and Duncan, S. A. (2010) Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum. BMC Dev. Biol. 10, 60.
29. Cowan, C. A., Klimanskaya, I., McMahon, J., Atienza, J., Witmyer, J., Zucker, J. P., Wang, S., Morton, C. C., McMahon, A. P., Powers, D., and Melton, D. A. (2004) Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353-1356. (Pubitemid 38375373)
30. Inman, G. J., Nicolas, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., and Hill, C. S. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74. (Pubitemid 34680517)
31. Cross, E. E., Thomason, R. T., Martinez, M., Hopkins, C. R., Hong, C. C., and Bader, D. M. (2011) Application of small organic molecules reveals cooperative TGFbeta and BMP regulation of mesothelial cell behaviors. ACS Chem. Biol. 6, 952-961.
32. Zimmerman, L. B., De Jesus-Escobar, J. M., and Harland, R. M. (1996) The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599-606. (Pubitemid 26299491)
33. Dou, C. L., Li, S., and Lai, E. (1999) Dual role of brain factor-1 in regulating growth and patterning of the cerebral hemispheres. Cereb. Cortex 9, 543-550. (Pubitemid 29441495)
34. Manuel, M. N., Martynoga, B., Molinek, M. D., Quinn, J. C., Kroemmer, C., Mason, J. O., and Price, D. J. (2011) The transcription factor Foxg1 regulates telencephalic progenitor proliferation cell autonomously, in part by controlling Pax6 expression levels. Neural Dev. 6, 9.
35. Broccoli, V., Boncinelli, E., and Wurst, W. (1999) The caudal limit of Otx2 expression positions the isthmic organizer. Nature 401, 164-168. (Pubitemid 29436319)
36. Ono, Y., Nakatani, T., Sakamoto, Y., Mizuhara, E., Minaki, Y., Kumai, M., Hamaguchi, A., Nishimura, M., Inoue, Y., Hayashi, H., Takahashi, J., and Imai, T. (2007) Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development 134, 3213-3225. (Pubitemid 47506159)
37. Morizane, A., Doi, D., Kikuchi, T., Nishimura, K., and Takahashi, J. (2011) Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J. Neurosci. Res. 89, 117-126.
38. Wada, T., Honda, M., Minami, I., Tooi, N., Amagai, Y., Nakatsuji, N., and Aiba, K. (2009) Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS One 4, e6722.
39. Kriks, S., Shim, J. W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., Yang, L., Beal, M. F., Surmeier, D. J., Kordower, J. H., Tabar, V., and Studer, L. (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-551.
40. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., and Moller, D. E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174. (Pubitemid 32995375)
41. Kim, E. K., Miller, I., Aja, S., Landree, L. E., Pinn, M., McFadden, J., Kuhajda, F. P., Moran, T. H., and Ronnett, G. V. (2004) C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J. Biol. Chem. 279, 19970-19976. (Pubitemid 38623439)
42. Yu, P. B., Deng, D. Y., Lai, C. S., Hong, C. C., Cuny, G. D., Bouxsein, M. L., Hong, D. W., McManus, P. M., Katagiri, T., Sachidanandan, C., Kamiya, N., Fukuda, T., Mishina, Y., Peterson, R. T., and Bloch, K. D. (2008) BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat. Med. 14, 1363-1369.
43. Vogt, J., Traynor, R., and Sapkota, G. P. (2011) The specificities of small molecule inhibitors of the TGFss and BMP pathways. Cell Signal. 23, 1831-1842.
44. Pevny, L. H., Sockanathan, S., Placzek, M., and Lovell-Badge, R. (1998) A role for SOX1 in neural determination. Development 125, 1967-1978. (Pubitemid 28274383)
45. Chung, S., Shin, B. S., Hedlund, E., Pruszak, J., Ferree, A., Kang, U. J., Isacson, O., and Kim, K. S. (2006) Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J. Neurochem. 97, 1467-1480. (Pubitemid 43725585)
46. Lang, R. J., Haynes, J. M., Kelly, J., Johnson, J., Greenhalgh, J., O'Brien, C., Mulholland, E. M., Baker, L., Munsie, M., and Pouton, C. W. (2004) Electrical and neurotransmitter activity of mature neurons derived from mouse embryonic stem cells by Sox-1 lineage selection and directed differentiation. Eur. J. Neurosci. 20, 3209-3221. (Pubitemid 40013532)
47. Fukuda, H., Takahashi, J., Watanabe, K., Hayashi, H., Morizane, A., Koyanagi, M., Sasai, Y., and Hashimoto, N. (2006) Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 24, 763-771. (Pubitemid 44464781)
48. Fasano, C. A., Chambers, S. M., Lee, G., Tomishima, M. J., and Studer, L. (2010) Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell. 6, 336-347.
49. Ohnuki, M., Takahashi, K., and Yamanaka, S. (2009) Generation and characterization of human induced pluripotent stem cells. Curr. Protoc. Stem Cell. Biol. Chapter 4, Unit 4A 2.
50. Neely, M. D., Tidball, A. M., Aboud, A. A., Ess, K. C., and Bowman, A. B. (2011) Induced Pluripotent Stem Cells (iPSCs): An Emerging Model System for the Study of Human Neurotoxicology, in Cell Culture Techniques (Aschner, M., Sunol, C., and Bal-Price, A., Eds.) pp 27-62, Springer, New York.
51. Lin, T., Ambasudhan, R., Yuan, X., Li, W., Hilcove, S., Abujarour, R., Lin, X., Hahm, H. S., Hao, E., Hayek, A., and Ding, S. (2009) A chemical platform for improved induction of human iPSCs. Nat. Methods 6, 805-808.
52. Paya, M., Segovia, J. C., Santiago, B., Galindo, M., del Rio, P., Pablos, J. L., and Ramirez, J. C. (2006) Optimising stable retroviral transduction of primary human synovial fibroblasts. J. Virol. Methods 137, 95-102. (Pubitemid 44189512)
53. Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., and Ben-Hur, T. (2001) Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19, 1134-1140. (Pubitemid 33115699)
54. Kwakye, G. F., Li, D., Kabobel, O. A., and Bowman, A. B. (2011) Cellular fura-2 manganese extraction assay (CFMEA). Curr. Protoc. Toxicol., Chapter 12, Unit12 18.
55. Perrier, A. L., Tabar, V., Barberi, T., Rubio, M. E., Bruses, J., Topf, N., Harrison, N. L., and Studer, L. (2004) Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 101, 12543-12548. (Pubitemid 39122060)